As the third quarter of 2026 nears its end, the selloff in pure-play quantum computing stocks looks increasingly like a valuation and commercialization reset across the sector.
Since reporting second-quarter results, IonQ (IONQ) shares have declined 7.3%, reflecting growing investor frustration with the gap between technological milestones and financial returns.
Direct peers Rigetti Computing (RGTI) and D-Wave Quantum (QBTS) have fared even worse, losing 10.6% and 16.2%, respectively, over the same period.
The weakness is striking because the period has brought a steady stream of positive developments, including IonQ’s SkyWater integration, its new Superion 256 platform and expanded commercial agreements.
Strategic progress is clearly arriving faster than financial monetization, creating a disconnect that the market is no longer willing to overlook.
IonQ’s second-quarter revenues surged 287% year over year, yet the company still posted a staggering $120.3 million adjusted EBITDA loss, underscoring how capital-intensive the scaling process remains.
The Federal Reserve raised rates to 3.75%-4.00% on September 16 and signaled another potential hike in 2026, keeping discount rates and funding costs elevated for speculative, long-duration technology assets.
Against this backdrop, investors are increasingly focused on revenue growth, improving profitability and commercial adoption, rather than technological milestones or government funding alone.
IonQ’s Remaining Performance Obligations reached $485 million in the second quarter, up sharply from $122 million a year earlier, signaling strong contractual demand building in the pipeline.
On September 8, IonQ raised its 2026 revenue outlook to $450-$460 million, a figure that includes the SkyWater buyout completed on July 31 of this year.
Management noted it is advancing multiple generations of semiconductor-based systems, including a path to 10,000 qubits in 2027, reinforcing the long-term growth case for the platform.
Customer deliveries of the new Superion 256 platform are expected in 2027, meaning near-term financial results will not yet reflect the revenue potential of that product line.
IonQ has continued to build commercial evidence through a $28 million DARPA contract extension along with new government and enterprise relationships formed in recent months.
However, some recently declared partnerships are not included in RPO or 2026 revenue guidance because they remain at an early and uncommitted stage of development.
The Zacks Consensus Estimate for IONQ’s third-quarter EPS is pegged at a loss of 22 cents, while the full-year 2026 estimate calls for a loss of $1.06 per share.
Those figures imply improvements of 93.9% and 41.8% over year-ago reported numbers, respectively, suggesting analysts do see a gradual trajectory toward narrowing losses over time.
Technically, IONQ is currently trading below both its 50-day and 200-day simple moving averages, indicating a weak setup with short- and longer-term price trends tilted firmly downward.
The stock’s position beneath both key moving averages suggests that a durable recovery has not yet taken shape in any meaningful or sustained way.
IONQ currently carries a Zacks Rank of 4, categorized as Sell, reflecting unfavorable earnings-estimate trends and cautious near-term expectations from analysts covering the name.
Given heavy losses, commercialization risks and persistent technical weakness, investors may consider selling IONQ now and reassessing once commercial execution provides clearer evidence of a sustained recovery.
